A Woman with Normotensive Primary Hyperaldosteronism.
Study Design
- Tipo de estudio
- Case Reports
- Población
- men
- Intervención
- A Woman with Normotensive Primary Hyperaldosteronism. None
- Comparador
- None
- Resultado primario
- None
- Dirección del efecto
- Positive
- Riesgo de sesgo
- High
Abstract
Normotensive hyperaldosteronism is a rare disorder. It is usually diagnosed with hypokalemia or an adrenal mass. Our patient was a 27-year-old female presented with weakness. She had normal blood pressure, hypokalemia, high plasma aldosterone level and suppressed plasma renin activity. After the saline load, test aldosterone didn't show suppression. Adrenal computed tomography revealed a left adrenal mass. The patient was treated with spironolactone and potassium supplement. Surgical adrenalectomy was done. Final pathologic diagnosis was benign adrenocortical adenoma without capsular invasion. In postoperative course serum, potassium was normal.
TL;DR
Final pathologic diagnosis was benign adrenocortical adenoma without capsular invasion andNormotensive hyperaldosteronism is a rare disorder.
Used In Evidence Reviews
Similar Papers
Journal of internal medicine · 2005
Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2018
Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.
Dermatologic clinics · 2010
Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2001
Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma.
American family physician · 2019
Clinically Relevant Drug-Drug Interactions in Primary Care.
Pharmacoepidemiology and drug safety · 2011